Search

Your search keyword '"Trinity Biotech PLC -- Product development"' showing total 18 results
Start Over Descriptor "Trinity Biotech PLC -- Product development"
18 results on '"Trinity Biotech PLC -- Product development"'

1. Trinity Biotech announces trial results for next-gen CGM technology

Subjects
Trinity Biotech PLC -- Product development, Biotechnology, Biotechnology industry -- Product development, Business, News, opinion and commentary
Abstract

Trinity Biotech announced the completion of its first pre-pivotal clinical trial in Europe for its next-generation continuous glucose monito technology. The study assessed the analytical performance of CGM technology enhancements [...]

Published
2024

2. Trinity Biotech Announces Success of Destiny Max Trials and First Orders From Japan

Subjects
Trinity Biotech PLC -- Product development, Biotechnology, Biotechnology industry -- Product development, Clinical trials
Abstract

DUBLIN, IRELAND, Nov 24, 2008 (MARKET WIRE via COMTEX) -- Trinity Biotech plc (NASDAQ: TRIB), a leading developer and manufacturer of diagnostic products for the point-of-care and clinical laboratory markets, […]

Published
2008

3. Calypte Biomedical and Trinity Biotech Enter Product Development Collaboration

Subjects
Calypte Biomedical Corp. -- Product development -- 00220518, Trinity Biotech PLC -- Product development, Biotechnology industry -- Product development, Medical test kit industry -- Product development, Business, Business, international
Abstract

BERKELEY, Calif.--(BW HealthWire)--Jan. 29, 1997--Calypte Biomedical Corporation (Nasdaq:CALY) announced today that it has entered into a collaborative research and product development agreement with Trinity Biotech plc of Dublin, Ireland (Nasdaq:TRIBY) [...]

Published
1997

4. Trinity Submits Rotavirus Test to FDA

Subjects
Trinity Biotech PLC -- Product development, Diagnostic reagents industry -- Product development, Business, News, opinion and commentary
Abstract

DUBLIN, Ireland, Dec. 12 /PRNewswire/ -- Trinity Biotech (Nasdaq: TRIBY) today announced that it has filed its Rotavirus Enzyme Immune Assay test with the U.S. Food and Drug Administration (FDA). [...]

Published
1996

5. TRINITY BIOTECH PLC FILES U.S. PATENT ON NEW RAPID, ONE-STEP AIDS TEST

Subjects
Trinity Biotech PLC -- Product development, Business, News, opinion and commentary
Abstract

DUBLIN, Ireland, June 17 /PRNewswire/ -- Trinity Biotech (Nasdaq: HIVSY) announced today that it has filed a U.S. patent application on its newly developed, one-step AIDS test. The test is [...]

Published
1994

6. TRINITY BIOTECH ANNOUNCES PRELIMINARY W.H.O. CLINICAL TRIAL RESULTS ON SEROCARD HIV-1/2 TEST

Subjects
Trinity Biotech PLC -- Product development, Medical equipment and supplies industry -- Product development, Business, News, opinion and commentary
Abstract

DUBLIN, Ireland, March 21 /PRNewswire/ -- Trinity Biotech (NASDAQ: HIVSY) announced results of a clinical trial on the company's rapid SeroCard HIV-1/2 test, reported by the Institute of Tropical Medicine, [...]

Published
1994

7. TRINITY BIOTECH RELEASES HIV TEST TRIAL RESULTS FROM INSTITUTE OF INFECTIOUS DISEASES - ITALY

Subjects
Trinity Biotech PLC -- Product development, Medical test kit industry -- Product development, Business, News, opinion and commentary
Abstract

DUBLIN, Ireland, Jan. 11 /PRNewswire/ -- Trinity Biotech (NASDAQ: HIVSY) announced results of evaluation of its SeroCard HIV-1 and HIV-1/2 by the Institute of Infectious Diseases at the University of [...]

Published
1994

8. TRINITY BIOTECH COMPLETES RAPID HEPATITIS B TEST

Subjects
Trinity Biotech PLC -- Product development, Medical test kit industry -- Product development, Business, News, opinion and commentary
Abstract

DUBLIN, Ireland, Jan. 4 /PRNewswire/ -- Trinity Biotech (NASDAQ: HIVSY) announced today that it has completed development of a rapid, whole blood hepatitis B test and will be commencing clinical [...]

Published
1994

9. TRINITY BIOTECH ANNOUNCES PRE-CLINICAL TRIAL RESULTS OF SALIVACARD AND SEROCARD HIV-1/2

Subjects
Trinity Biotech PLC -- Product development, Medical test kit industry -- Product development, Business, News, opinion and commentary
Abstract

DUBLIN, Ireland, Dec. 14 /PRNewswire/ -- Trinity Biotech (NASDAQ: HIVSY) announced that its initial pre-clinical trials with both HIV-1/2 SeroCard and HIV-1/2 SalivaCard have been completed. The results, collated from [...]

Published
1993

10. Trinity & Harvard develop home HIV test

Subjects
Trinity Biotech PLC -- Product development, Harvard Scientific -- Product development, Medical test kit industry -- Product development, HIV testing -- Equipment and supplies, HIV home tests -- Product development, Business, Health care industry, Pharmaceuticals and cosmetics industries
Published
1994

11. Trinity to begin trials of HIV saliva test

Subjects
Trinity Biotech PLC -- Product development, Diagnostic reagents industry -- Product development, HIV testing -- Research, Business, Health care industry, Pharmaceuticals and cosmetics industries
Published
1993

12. Product development collaboration entered to develop test

Subjects
Calypte Biomedical Corp. -- Product development -- 00220518, Trinity Biotech PLC -- Product development, HIV testing -- Product development
Abstract

Calypte Biomedical Corp., Berkeley, California, announced that it has entered into a collaborative research and product development agreement with Trinity Biotech plc, Dublin, Ireland, to develop a rapid, one-step HIV [...]

Published
1997

13. Trinity Biotech

Subjects
Trinity Biotech PLC -- Product development, Biotechnology industry -- Product development, HIV testing -- Licensing, certification and accreditation, Economics, Health care industry, High technology industry
Abstract

Trinity Biotech (Dublin, Ireland) reported that the FDA has approved a waiver under the Clinical Laboratory Improvements Amendments of 1988 for the Uni-Gold Recombigen HIV test. The waiver means that [...]

Published
2005

14. Trinity Biotech plc

Subjects
Trinity Biotech PLC -- Product development, HIV testing -- Licensing, certification and accreditation, Biotechnology industry -- Product development, Biotechnology industry, Business, Business, international
Abstract

Trinity Biotech plc, of Dublin, Ireland, received FDA approval for the use of its Uni-Gold Recombigen HIV test with finger-stick whole-blood samples. The test gives results within 10 minutes and [...]

Published
2004

15. Trinity Biotech plc

Subjects
Trinity Biotech PLC -- Product development, Biotechnology industry -- Product development, Biotechnology industry, Business, Business, international
Abstract

* Trinity Biotech plc, of Dublin, Ireland, received clearance from the FDA to market its Captia HSV IgG Type Specific ELISAs in the U.S. The products are approved for the [...]

Published
2004

16. Trinity Biotech

Subjects
Trinity Biotech PLC -- Product development, Medical test kit industry -- Product development, HIV testing -- Licensing, certification and accreditation, Economics, Health care industry, High technology industry, Trinity Uni-Gold Recombigen HIV (Medical test kit) -- Licensing, certification and accreditation
Abstract

* Trinity Biotech (Dublin, Ireland) received FDA approval to market its Uni-Gold Recombigen HIV test in the U.S. The product is approved for the detection of antibodies to HIV in [...]

Published
2004

17. Trinity Biotech announces preliminary results on SeroCard HIV-1/2 test

Subjects
Trinity Biotech PLC -- Product development, Testing equipment -- Product development, HIV testing -- Product development
Abstract

WHO Clinical Trials Trinity Biotech, Dublin, Ireland, announced results of a clinical trial on the company's rapid SeroCard HIV -1/2 test, reported by the Institute of Tropical Medicine, a World [...]

Published
1994

18. Trinity Biotech announces pre-clinical trial results of SalivaCard and SeroCard HIV-1/2

Subjects
Trinity Biotech PLC -- Product development, HIV testing -- Equipment and supplies, Diagnostic reagents and test kits -- Product development
Abstract

Ireland Trinity Biotech, Dublin, Ireland, announced that its initial pre-clinical trials with both HIV-1/2 SeroCard and HIV-1/2 SalivaCard have been completed. The results, collated from 10 centers in Italy, Sweden, [...]

Published
1994

Catalog

Books, media, physical & digital resources
See catalog results